Your session is about to expire
← Back to Search
Other
Restrata Graft for Head and Neck Cancers
Phase 2
Waitlist Available
Led By Robert Lindau, MD
Research Sponsored by Nebraska Methodist Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks post operation
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether using a special type of graft along with a skin graft helps adult patients heal better after certain forearm surgeries.
Eligible Conditions
- Head and Neck Cancers
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 weeks post-operation
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks post-operation
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Percentage of surface area
Tendon exposure
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: B - Restrata GraftExperimental Treatment1 Intervention
Group II: A - Standard of CareActive Control1 Intervention
Find a Location
Who is running the clinical trial?
Nebraska Methodist Health SystemLead Sponsor
2 Previous Clinical Trials
750 Total Patients Enrolled
Acera Surgical, Inc.Industry Sponsor
6 Previous Clinical Trials
162 Total Patients Enrolled
Robert Lindau, MDPrincipal InvestigatorNebraska Methodist Hospital
Share this study with friends
Copy Link
Messenger